Scope cleaning procedures were questioned after the virus started appearing in cities across the United States and Olympus responded by updating cleaning protocols to halt the outbreak of CRE. The company is urging hospitals to implement the newest cleaning procedures “as soon as possible.”
Olympus’ new cleaning instructions, released on Thursday, March 26th, included a number of additional cleaning steps and require the use of a “small bristle cleaning brush.” The company said it would send the brushes to facilities by early May. Food and Drug Administration (FDA) released a statement calling the new cleaning procedures, “robust and [demonstrating] consistent and reliable cleaning and high-level disinfection.”
The team of Philadelphia personal injury attorneys at Messa & Associates is highly experienced in handling dangerous drug and medical device cases. Firm founder, Joseph L. Messa, Jr., has earned multiple seven-, eight-, and nine-figure verdicts and settlements for clients injured by defective drugs. Firm partner, Eric H. Weitz, served as co-counsel on Topamax mass tort cases in Philadelphia that earned over $14 million for victims of Topamax-related birth defects. Claudine Q. Homolash, of counsel attorney and author of a dangerous drug blog called Little Ms. Pharma, has dedicated her career to fighting for victims of dangerous drugs and medical devices.
Messa & Associates is armed with the right attorneys and the necessary connections to successfully litigate defective drug and medical device claims. If you or a loved one has become infected by the antibiotic resistant superbug after undergoing an endoscopic procedure, contact an attorney from Messa & Associates. Call 1-877-MessaLaw for a free consultation or submit an online inquiry for a free case evaluation.
Joseph L. Messa, Jr. is the founding partner of Messa & Associates, P.C. He is an AV-rated attorney (highest rating available), listed in the Bar Register of Preeminent Lawyers. Read More